MSD has said it will cut $3 billion off its annual costs by the end of 2027 as it prepares for the end of patent protection for blockbuster cancer drug Keytruda the following year.

MSD is preparing to take on Takeda in the dengue fever vaccine market, moving its V181 candidate into phase 3.

Uncover the top onboarding software of 2025. Transform your hiring process with user-friendly tools that boost employee satisfaction and retention rates.

According to™, The precision livestock farming market is projected to reach USD 12.12 billion by 2030 from USD 7.94 ...

Everything you need to know about iOS 26 features and the upcoming Apple iPhone update Here's how you can access the beta OSes for iPhone and iPad, and when you can expect the final release.

Barclays raised its price target on SAP (ETR:SAPG) to €300 from €275, citing accelerating cloud adoption, rising AI demand, and the company’s Business Data Cloud (BDC) as key growth drivers. The bank ...

Objective The rising burden of non-communicable diseases (NCDs), including mental health disorders (MHDs) such as anxiety and ...